Comparison Overview
Eli Lilly Italia

Eli Lilly Italia
Viale Gramsci 731-733, Sesto Fiorentino, 50019, IT
Last Update: 08/03/2026
L’attività di Lilly Italia inizia nel 1959 a Sesto Fiorentino, Firenze. Oggi l’affiliata copre una superficie di 85.000 mq, impiega circa 1.500 persone, di cui oltre 900 nel sito manifatturiero, uno dei più grandi stabilimenti per la produzione di farmaci da biotecnolog...

Viatris
Pittsburgh, US
Last Update: 04/04/2026
Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to ...
Compliance Ranges Comparison

Eli Lilly Italia







Viatris






Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Eli Lilly Italia in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Viatris in 2026.
Incident History - Eli Lilly Italia (X = Date, Y = Severity)
Eli Lilly Italia cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Viatris (X = Date, Y = Severity)
Viatris cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

Eli Lilly Italia

Viatris
FAQ
Latest Global CVEs
PraisonAI before 1.5.115 contains a path traversal vulnerability in MultiAgentMonitor that fails to sanitize agent IDs when building file paths. Attackers can include traversal sequences like ../ in agent IDs to read, write, or overwrite arbitrary files, enabling sensitive disclosure, denial of service, or code execution.
PraisonAI before 1.5.115 contains an information disclosure vulnerability in the MultiAgentLedger component that allows attackers to access sensitive data by registering agents with duplicate IDs. Attackers can exploit the lack of agent ID uniqueness enforcement to share ledger instances and expose system prompts and conversation history between agents.
PraisonAI before 1.5.128 contains a cross-origin agent execution vulnerability in the AGUI endpoint that allows remote attackers to trigger arbitrary agent execution. The POST /agui endpoint lacks authentication and hardcodes Access-Control-Allow-Origin: * headers, combined with Starlette's Content-Type-agnostic JSON parsing, enabling attackers to bypass CORS preflight checks via simple requests and exfiltrate sensitive agent responses including tool execution results and environment data.
PraisonAI before 4.5.128 contains an arbitrary shell command execution vulnerability where the UI modules hardcode approval_mode to auto, overriding administrator configuration from PRAISON_APPROVAL_MODE environment variable. Authenticated attackers can instruct the LLM agent to execute arbitrary shell commands via subprocess.run with shell=True, bypassing the manual approval gate and insufficient command sanitization blocklists.
PraisonAI before 1.5.128 caches tool approval decisions by tool name only, not by invocation arguments, allowing subsequent execute_command calls to bypass approval prompts. Attackers can exploit this by obtaining initial approval for a benign command, then silently exfiltrate API keys and credentials via subsequent shell commands without user consent.